Bartlett et al. examined the role of miRNAs in pathway alterations in CRC and concluded that miR-155 and miR-22 significantly influenced these pathways (p = 0.0001) and TGF-β signaling (p = 0.008) [18]. This evidence concerns the gene TGFB1 and colorectal carcinoma.